Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link. One out of the three major indices are trading lower today with the Dow Jones Industrial Average ( ^DJI) trading down 16 points (-0.1%) at 16,836 as of Monday, June 30, 2014, 12:55 PM ET. The NYSE advances/declines ratio sits at 1,605 issues advancing vs. 1,347 declining with 197 unchanged. The Financial sector currently sits down 0.1% versus the S&P 500, which is unchanged. Top gainers within the sector include Zillow ( Z), up 3.3%, KKR ( KKR), up 1.9%, Orix ( IX), up 1.5%, National Bank of Greece ( NBG), up 1.4% and Weyerhaeuser ( WY), up 1.2%. On the negative front, top decliners within the sector include Rayonier ( RYN), down 26.5%, Vornado Realty ( VNO), down 1.1%, Deutsche Bank ( DB), down 0.9%, Wells Fargo ( WFC), down 0.9% and Charles Schwab ( SCHW), down 0.8%. TheStreet would like to highlight 3 stocks pushing the sector higher today: 3. CME Group ( CME) is one of the companies pushing the Financial sector higher today. As of noon trading, CME Group is up $0.62 (0.9%) to $71.04 on light volume. Thus far, 567,863 shares of CME Group exchanged hands as compared to its average daily volume of 1.6 million shares. The stock has ranged in price between $70.56-$71.70 after having opened the day at $70.85 as compared to the previous trading day's close of $70.42. CME Group Inc., through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. CME Group has a market cap of $23.7 billion and is part of the financial services industry. Shares are down 10.2% year-to-date as of the close of trading on Friday. Currently there are 7 analysts who rate CME Group a buy, no analysts rate it a sell, and 5 rate it a hold. TheStreet Ratings rates CME Group as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, growth in earnings per share, reasonable valuation levels, expanding profit margins and increase in net income. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself. Get the full CME Group Ratings Report now. 3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.